Nevro in Menlo Park, Calif., a medical device company, has announced
the issuance of four additional key patents related to the company's Senza(R) system and High-Frequency Spinal Cord Stimulation therapy.
The Senza system, which aims at providing relief from chronic pain, is available in Europe and Australia. It is presently undergoing investigation in a clinical trial in the United States.
More Articles on Pain Management: Dr. Ritu Verma Joins American Spine
Georgia Rep. Tom Weldon to Sponsor Pain Clinic Regulation Bill
Prospira PainCare to Deploy Athenahealth's Cloud-Based & EHR Services